Ninety One (UK)
NVS icon

Ninety One (UK)’s Novartis NVS Stock Holding History

Ninety One (UK)’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.9K Hold
76
– – ﹤0.01% 259
2026
Q1 		$11.6K Buy
76
+24
+46% +$3.68K ﹤0.01% 226
2025
Q4 		$7.17K Hold
52
– – ﹤0.01% 220
2025
Q3 		$6.67K Hold
52
– – ﹤0.01% 208
2025
Q2 		$6.29K Sell
52
-95
-65% -$10.7K ﹤0.01% 199
2025
Q1 		$16.4K Hold
147
– – ﹤0.01% 190
2024
Q4 		$14.3K Hold
147
– – ﹤0.01% 189
2024
Q3 		$16.9K Hold
147
– – ﹤0.01% 192
2024
Q2 		$15.7K Hold
147
– – ﹤0.01% 185
2024
Q1 		$14.2K Hold
147
– – ﹤0.01% 183
2023
Q4 		$14.8K Buy
+147
New +$14.2K ﹤0.01% 176
2021
Q2 		– Sell
-139
Closed -$12K – 215
2021
Q1 		$12K Hold
139
– – ﹤0.01% 213
2020
Q4 		$13K Hold
139
– – ﹤0.01% 217
2020
Q3 		$12K Buy
139
+1
+0.7% +$87 ﹤0.01% 218
2020
Q2 		$12K Buy
+138
New +$11.9K ﹤0.01% 229

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Ninety One (UK)'s NVS Position: Q2 2026 in Review

Ninety One (UK) held its Novartis (NVS) position steady in Q2 2026 at 76 shares worth $11.9K. The position accounts for ﹤0.01% of the portfolio, ranked #259.

Ninety One (UK) first reported a position in NVS in Q2 2020 and has held it in 15 quarters since. The position peaked at $16.9K in Q3 2024. 1,619 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Ninety One (UK) held 76 shares of Novartis worth $11.9K as of Q2 2026.
  • Ninety One (UK) left its Novartis share count unchanged in Q2 2026.
  • Novartis made up ﹤0.01% of Ninety One (UK)'s portfolio in Q2 2026, its #259 holding.
  • Ninety One (UK) first reported a position in Novartis in Q2 2020 and has held it in 15 quarters since.
  • Ninety One (UK)'s Novartis position peaked at $16.9K in Q3 2024.
  • 1,619 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Ninety One (UK)'s 13F filing for Q2 2026, filed 16 Jul 2026.